5 Most Promising Psychedelic Stocks According to Hedge Funds

4. COMPASS Pathways plc (NASDAQ:CMPS)

Number of Hedge Fund Investors In Q3 2023: 21

COMPASS Pathways plc (NASDAQ:CMPS) is a British company developing treatments for nervous system disorders. December 2023 was a great month for the firm as its trial for psilocybin in PTSD patients yielded favorable results.

During 2023’s September quarter, 21 out of the 910 hedge funds profiled by Insider Monkey had held a stake in the company. COMPASS Pathways plc (NASDAQ:CMPS)’s biggest hedge fund investor is Catherine D. Wood’s ARK Investment Management due to its $18 million investment.

Follow Compass Pathways Plc (NASDAQ:CMPS)